Skip to main content
$7.47 At close · Jul 27
Market Cap
$54.62M
Shares
7.31M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$22.36M -17.3%
FY2025 Revenue FY2013–FY2025
Net Income
-$41.71M +2.4%
FY2025 Net Income FY2012–FY2025
Gross Margin
56.64% +7.6pp
FY2025 Gross Margin FY2014–FY2025
Operating Margin
-163.94% +49.6pp
FY2025 Operating Margin FY2014–FY2025
Diluted EPS
$10.12 -17.5%
FY2025 Diluted EPS FY2020–FY2025
Operating Cash Flow
-$25.94M +32.7%
FY2025 Operating Cash Flow FY2012–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012
$21.19M $22.36M $27.04M $20.35M $27.66M $20.51M $7.58M $7.56M $7.39M $5.17M $2.8M $823K $51K $0
$9.21M $9.69M $13.77M $14.37M $18M $16.55M $5.06M $4.96M $5.63M $3.86M $3.36M $1.68M $2.27M $0
$11.98M $12.67M $13.27M $5.98M $9.66M $3.96M $2.51M $2.6M $1.77M $1.31M -$830K -$855K -$2.71M $0
56.64% 49.06% 29.4% 34.91% 19.32% 33.17% 34.36% 23.87% 25.36% -29.61% -103.89% -5317.65%
$12.07M $13.79M $24.18M $20.25M $19.65M $17.22M $4.43M $3.69M $3.68M $3.3M $2.15M $2.57M $3.94M $4.91M $1.5M
$15.11M $15.19M $20.48M $18.14M $16.49M $23.53M $12.76M $5.48M $5.47M $4.73M $3.38M $2.95M $3.64M $6.3M $2.18M
$2.13M $2.83M $6.1M $4.51M $4.36M $4.18M
$46.54M $49.32M $71.01M $62.17M $66.47M $80.46M $32.42M $20.3M $19.45M $15.73M $10.27M $6.84M $8.65M $13.56M
-$34.56M -$36.66M -$57.74M -$56.19M -$56.81M -$76.49M -$29.9M -$17.71M -$17.69M -$14.42M -$11.1M -$7.7M -$11.36M -$13.56M -$3.97M
-163.94% -213.55% -276.09% -205.42% -372.9% -394.71% -234.22% -239.22% -278.9% -396.04% -935.36% -22270.59%
$3.02M
$814K $943K $1.12M $1.87M $506K $44K $61K $16K $0
-$6.04M -$4.95M $13.15M -$3.17M -$5.38M -$235K $458K -$31K -$115K -$1.32M $214K $556K -$1.52M -$369K -$1.71M
-$40.6M -$41.61M -$44.6M -$59.36M -$62.19M -$76.73M -$29.45M -$17.74M -$17.8M -$15.74M -$10.89M -$7.14M $12.88M $13.93M $5.69M
$105K -$1.85M $64K $4000 $32K
-$40.74M -$41.71M -$42.75M -$59.43M -$62.19M -$76.76M -$29.45M -$17.74M -$17.8M -$15.74M -$10.89M -$7.14M -$12.88M -$13.93M -$5.69M
-186.56% -158.09% -292% -224.88% -374.21% -388.66% -234.63% -240.78% -304.51% -388.41% -867.8% -25249.02%
-$59.96M -$67.52M -$33.1M -$20.89M -$18.3M -$16M -$11.61M -$7.3M -$16.06M -$13.93M
-$55.92M -$61.74M -$40.98M -$63.51M -$63.84M -$78.77M -$20M -$5.69M
USD/shares $10.12 $12.27 $38.60 $50.80 $81.40 $80.20
USD/shares $10.12 $12.27 $38.60 $50.80 $81.40 $80.20
shares 3.98M 2.45M 1.42M 1.18M 829.59K 298.17K 113.31K 58.53K 481.41K 260.15K 94.89K 433.95K 183.13K 618.75K
shares 3.98M 2.45M 1.42M 1.18M 829.59K 298.17K 113.31K 58.53K 481.41K 260.15K 94.89K 433.95K 183.13K 618.75K
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Peer median 1.12×
EV/EBIT
P/E (TTM)
0.92×
Peer median 18.32×

Peer medians compare against the 27 similar-size Health Information Services companies (of 54 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Service $14,929,000 $20,197,000 $13,084,000 $17,859,000 $2,085,000 $1,809,000
Hardware and Consumable Products $7,430,000 $6,843,000 $7,268,000 $9,797,000 $18,428,000
Commercial $16,377,000 $851,000
Consumers $8,293,000 $11,279,000 $19,662,000
Development Services Per Exclusive Agreement $4,592,000 $5,506,000
Development Services Per Exclusive Agreement Year One $4,000,000
Development Services Per Exclusive Agreement Year Three $2,098,000
Development Services Per Exclusive Agreement Year Two $2,494,000 $1,506,000
National Health Plan Statement of Work Agreement $962,000 $1,778,000
Sales Channel Business to Business to Consumer (B2B2C) $5,005,000 $3,593,000
Sales Channel Strategic Partnerships $7,054,000 $12,784,000
Product $17,793,000 $5,767,000
Key facts CIK 1533998 CUSIP 23725P308 13F (30d) 2 filings 2 filers Visit website Investor relations